These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22084083)

  • 1. Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.
    Painter CA; Negroni MP; Kellersberger KA; Zavala-Ruiz Z; Evans JE; Stern LJ
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19329-34. PubMed ID: 22084083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
    Schulze MS; Anders AK; Sethi DK; Call MJ
    PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain.
    Stratikos E; Wiley DC; Stern LJ
    J Immunol; 2004 Jan; 172(2):1109-17. PubMed ID: 14707085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.
    Narayan K; Chou CL; Kim A; Hartman IZ; Dalai S; Khoruzhenko S; Sadegh-Nasseri S
    Nat Immunol; 2007 Jan; 8(1):92-100. PubMed ID: 17143275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.
    Poluektov YO; Kim A; Hartman IZ; Sadegh-Nasseri S
    PLoS One; 2013; 8(8):e71228. PubMed ID: 23951115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Thermodynamic Mechanism of Peptide-MHC Class II Complex Formation Is a Determinant of Susceptibility to HLA-DM.
    Ferrante A; Templeton M; Hoffman M; Castellini MJ
    J Immunol; 2015 Aug; 195(3):1251-61. PubMed ID: 26116504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.
    Ferrante A; Gorski J
    J Immunol; 2010 Feb; 184(3):1153-8. PubMed ID: 20038641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
    Stratikos E; Mosyak L; Zaller DM; Wiley DC
    J Exp Med; 2002 Jul; 196(2):173-83. PubMed ID: 12119342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetic basis of peptide exchange catalysis by HLA-DM.
    Zarutskie JA; Busch R; Zavala-Ruiz Z; Rushe M; Mellins ED; Stern LJ
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12450-5. PubMed ID: 11606721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
    Murthy VL; Stern LJ
    Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.
    Yin L; Trenh P; Guce A; Wieczorek M; Lange S; Sticht J; Jiang W; Bylsma M; Mellins ED; Freund C; Stern LJ
    J Biol Chem; 2014 Aug; 289(34):23449-64. PubMed ID: 25002586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1.
    Zavala-Ruiz Z; Sundberg EJ; Stone JD; DeOliveira DB; Chan IC; Svendsen J; Mariuzza RA; Stern LJ
    J Biol Chem; 2003 Nov; 278(45):44904-12. PubMed ID: 12952957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
    Schulze MS; Wucherpfennig KW
    Curr Opin Immunol; 2012 Feb; 24(1):105-11. PubMed ID: 22138314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short peptide sequences mimic HLA-DM functions.
    Chou CL; Mirshahidi S; Su KW; Kim A; Narayan K; Khoruzhenko S; Xu M; Sadegh-Nasseri S
    Mol Immunol; 2008 Apr; 45(7):1935-43. PubMed ID: 18054387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DM mediates epitope selection by a "compare-exchange" mechanism when a potential peptide pool is available.
    Ferrante A; Anderson MW; Klug CS; Gorski J
    PLoS One; 2008; 3(11):e3722. PubMed ID: 19005572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
    Ghosh P; Amaya M; Mellins E; Wiley DC
    Nature; 1995 Nov; 378(6556):457-62. PubMed ID: 7477400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release.
    Negroni MP; Stern LJ
    PLoS One; 2018; 13(7):e0199704. PubMed ID: 29965980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection.
    Pos W; Sethi DK; Call MJ; Schulze MS; Anders AK; Pyrdol J; Wucherpfennig KW
    Cell; 2012 Dec; 151(7):1557-68. PubMed ID: 23260142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.
    Painter CA; Stern LJ
    Immunol Rev; 2012 Nov; 250(1):144-57. PubMed ID: 23046127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.